BioTransplant, Inc.
🏢 View company profile →14Patents
0Active
14Granted
28Portfolio score
Filing activity: Oct 8, 1993 → Jul 7, 2000
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6153428A | .alpha.(1,3) galactosyltransferase negative porcine cells | Chemistry; Metallurgy | 61 | Expired |
| US5922601A | High efficiency gene trap selection of regulated genetic loci | Chemistry; Metallurgy | 32 | Expired |
| US6703209B1 | Porcine totipotent cells and method for long-term culture | Chemistry; Metallurgy | 24 | Expired |
| US5951983A | Methods of inhibiting T cell mediated immune responses with humanized LO-CD2A-specific antibodies | Chemistry; Metallurgy | 23 | Expired |
| US5863528A | Porcine cytokines | Chemistry; Metallurgy | 17 | Expired |
| US5589582A | Polynucleotides en coding porcine cytokines | Chemistry; Metallurgy | 8 | Expired |
| US6849258B1 | LO-CD2a antibody and uses thereof for inhibiting T cell activation and proliferation | Chemistry; Metallurgy | 4 | Expired |
| US6261806A | Molecular sequence of swine retrovirus and methods of use | Chemistry; Metallurgy | 3 | Expired |
| US6482937B1 | Porcine Oct-4 promoter | Chemistry; Metallurgy | 2 | Expired |
| US5858963A | Inducing xenograft tolerance and porcine cytokines therefor | Chemistry; Metallurgy | 2 | Expired |
| US5962644A | Porcine CD34 | Human Necessities | 0 | Expired |
| US5856106A | Determination of antibody production against administered therapeutic glycoproteins, especially monoclonal antibodies | Emerging Cross-Sectional Technologies | 0 | Expired |
| US6461811B1 | Gamma-herpes virus DNA and methods of use | Chemistry; Metallurgy | 0 | Expired |
| US6670151B1 | Porcine stem cell factor varients and recombinant cells expressing such polypeptides | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.